SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-048551
Filing Date
2022-02-22
Accepted
2022-02-22 16:16:05
Documents
14
Period of Report
2022-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d307171d8k.htm   iXBRL 8-K 28350
2 EX-10.1 d307171dex101.htm EX-10.1 53683
3 EX-99.1 d307171dex991.htm EX-99.1 9751
  Complete submission text file 0001193125-22-048551.txt   235806

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atnx-20220218.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20220218_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20220218_pre.xml EX-101.PRE 11263
8 EXTRACTED XBRL INSTANCE DOCUMENT d307171d8k_htm.xml XML 3338
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 22658258
SIC: 2834 Pharmaceutical Preparations